---
$id: https://graph.org.ai/products/commodity/51263013
$type: Product
source: UNSPSC
code: "51263013"
title: "Terazosin monohydrochloride dihydrate"
class: "51263000"
classTitle: "Adrenergic blocking agent piperazines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Terazosin monohydrochloride dihydrate

**UNSPSC Code**: 51263013
**Class**: [Adrenergic blocking agent piperazines](Adrenergic blocking agent piperazines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H25N5O4.ClH.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D32S14F082, chemically known as methanone, (4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl)(tetrahydro-2-furanyl)-, hydrochloride, hydrate (1:1:2), but more generally known as terazosin monohydrochloride dihydrate, which bears US NIH Compound Identifier 63016. European Medicines Agency schedules terazosin monohydrochloride dihydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10907MIG. Most nations, for tariff purposes, schedule terazosin monohydrochloride dihydrate under HS 29349990. SMILES: COC1CC2C(CC1OC)NC(NC2N)N3CCN(CC3)C(=O)C4CCCO4.O.O.CL.

